Dear OHDSI Korean friends,
I'm contacting you from Denmark and in English, you have my apologies for that.
Our government is having a look at KoNECT, the Korean Clinical Trial platform (https://www.konect.or.kr/).
At the same time we are evaluating the OHDSI OMOP CDM for our research and bedside data.
Can anyone enlighten us if KoNECT is anyhow including OMOP CDM in its design/platform/tools?
Thanks in advance for your time and for performing CDM work which is inspiring for the rest of us.